DK0521977T3 - Kontrastmidler - Google Patents
KontrastmidlerInfo
- Publication number
- DK0521977T3 DK0521977T3 DK91906843.7T DK91906843T DK0521977T3 DK 0521977 T3 DK0521977 T3 DK 0521977T3 DK 91906843 T DK91906843 T DK 91906843T DK 0521977 T3 DK0521977 T3 DK 0521977T3
- Authority
- DK
- Denmark
- Prior art keywords
- contrast agents
- contrast
- complexes
- agents
- enhacing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F11/00—Compounds containing elements of Groups 6 or 16 of the Periodic System
- C07F11/005—Compounds containing elements of Groups 6 or 16 of the Periodic System compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2123/00—Preparations for testing in vivo
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909006977A GB9006977D0 (en) | 1990-03-28 | 1990-03-28 | Compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0521977T3 true DK0521977T3 (da) | 1996-09-30 |
Family
ID=10673438
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK91906843.7T DK0521977T3 (da) | 1990-03-28 | 1991-03-27 | Kontrastmidler |
Country Status (18)
Country | Link |
---|---|
US (2) | US5458869A (da) |
EP (2) | EP0521977B1 (da) |
JP (1) | JPH06507147A (da) |
AT (1) | ATE142508T1 (da) |
AU (1) | AU645796B2 (da) |
CA (1) | CA2079212A1 (da) |
DE (1) | DE69122092T2 (da) |
DK (1) | DK0521977T3 (da) |
ES (1) | ES2091323T3 (da) |
FI (1) | FI924297A0 (da) |
GB (1) | GB9006977D0 (da) |
HK (1) | HK219596A (da) |
HU (2) | HU9203086D0 (da) |
LT (1) | LT3535B (da) |
LV (1) | LV10056B (da) |
NO (1) | NO923739L (da) |
SG (1) | SG43931A1 (da) |
WO (1) | WO1991014460A1 (da) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9006977D0 (en) * | 1990-03-28 | 1990-05-23 | Nycomed As | Compositions |
WO1992017215A1 (en) | 1990-03-28 | 1992-10-15 | Nycomed Salutar, Inc. | Contrast media |
SG43930A1 (en) * | 1991-03-27 | 1997-11-14 | Nycomed Salutar Inc | Contrast media |
US5330742A (en) * | 1991-08-05 | 1994-07-19 | Mallinckrodt Medical, Inc. | Methods and compositions for magnetic resonance imaging |
WO1993002713A1 (en) * | 1991-08-05 | 1993-02-18 | Mallinckrodt Medical, Inc. | Heavy metal clusters for use as imaging agents |
US5364953A (en) * | 1992-11-05 | 1994-11-15 | Mallinckrodt Medical, Inc. | High relaxivity, paramagnetic, metal clusters for magnetic resonance imaging |
GB9407812D0 (en) * | 1994-04-20 | 1994-06-15 | Nycomed Salutar Inc | Compounds |
GB9420390D0 (en) * | 1994-10-10 | 1994-11-23 | Nycomed Salutar Inc | Liposomal agents |
US5717121A (en) * | 1995-06-07 | 1998-02-10 | Nycomed Salutar, Inc. | Preparation and use of contrast agents |
GB9601340D0 (en) * | 1996-01-23 | 1996-03-27 | Nycomed Salutar Inc | Contrast media |
WO1997030459A1 (en) * | 1996-02-14 | 1997-08-21 | Philips Electronics N.V. | X-ray examination apparatus with x-ray filter |
US5804161A (en) * | 1996-05-14 | 1998-09-08 | Nycomed Salutar Inc. | Contrast agents |
US6524553B2 (en) | 1998-03-31 | 2003-02-25 | Bristol-Myers Squibb Pharma Company | Quinolone vitronectin receptor antagonist pharmaceuticals |
US6548663B1 (en) | 1998-03-31 | 2003-04-15 | Bristol-Myers Squibb Pharma Company | Benzodiazepine vitronectin receptor antagonist pharmaceuticals |
US6537520B1 (en) | 1998-03-31 | 2003-03-25 | Bristol-Myers Squibb Pharma Company | Pharmaceuticals for the imaging of angiogenic disorders |
WO2000035492A2 (en) | 1998-12-18 | 2000-06-22 | Du Pont Pharmaceuticals Company | Vitronectin receptor antagonist pharmaceuticals |
US6511649B1 (en) | 1998-12-18 | 2003-01-28 | Thomas D. Harris | Vitronectin receptor antagonist pharmaceuticals |
EP1140864A2 (en) | 1998-12-18 | 2001-10-10 | Du Pont Pharmaceuticals Company | Vitronectin receptor antagonist pharmaceuticals |
US6794518B1 (en) | 1998-12-18 | 2004-09-21 | Bristol-Myers Squibb Pharma Company | Vitronectin receptor antagonist pharmaceuticals |
US6569402B1 (en) | 1998-12-18 | 2003-05-27 | Bristol-Myers Squibb Pharma Company | Vitronectin receptor antagonist pharmaceuticals |
US6596259B1 (en) * | 1998-12-22 | 2003-07-22 | University Of Puerto Rico | Metal based cubane structure contained in an octanuclear complex stable over several oxidation states and a method of producing the same |
US7807137B1 (en) | 1998-12-22 | 2010-10-05 | University Of Puerto Rico | Iron-based contrast agent |
US6656448B1 (en) | 2000-02-15 | 2003-12-02 | Bristol-Myers Squibb Pharma Company | Matrix metalloproteinase inhibitors |
US6878363B2 (en) | 2000-05-17 | 2005-04-12 | Bristol-Myers Squibb Pharma Company | Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging |
NZ516746A (en) | 2000-06-01 | 2004-02-27 | Bristol Myers Squibb Pharma | Lactams substituted by cyclic succinates as inhibitors of A-beta protein production |
US6770259B2 (en) | 2000-11-03 | 2004-08-03 | Bristol-Myers Squibb Pharma Company | Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
US7928278B2 (en) * | 2001-06-12 | 2011-04-19 | University Of Florida Research Foundation, Inc. | Method and apparatus for producing near-infrared radiation |
US6838074B2 (en) | 2001-08-08 | 2005-01-04 | Bristol-Myers Squibb Company | Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent |
HUP0401904A3 (en) | 2001-08-08 | 2009-01-28 | Bristol Myers Squibb Pharma Co | Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent |
US7344702B2 (en) | 2004-02-13 | 2008-03-18 | Bristol-Myers Squibb Pharma Company | Contrast agents for myocardial perfusion imaging |
US20050106100A1 (en) * | 2003-09-03 | 2005-05-19 | Harris Thomas D. | Compounds containing matrix metalloproteinase substrates and methods of their use |
US7485283B2 (en) | 2004-04-28 | 2009-02-03 | Lantheus Medical Imaging | Contrast agents for myocardial perfusion imaging |
JP4322781B2 (ja) * | 2004-11-08 | 2009-09-02 | 富士フイルム株式会社 | 撮像装置 |
WO2007005491A1 (en) * | 2005-06-30 | 2007-01-11 | Bristol-Myers Squibb Pharma Company | Hydrazide conjugates as imaging agents |
US7824659B2 (en) | 2005-08-10 | 2010-11-02 | Lantheus Medical Imaging, Inc. | Methods of making radiolabeled tracers and precursors thereof |
US9149545B2 (en) * | 2005-11-02 | 2015-10-06 | General Electric Company | Nanoparticle-based imaging agents for X-ray/computed tomography and methods for making same |
US20070098642A1 (en) * | 2005-11-02 | 2007-05-03 | General Electric Company | Nanoparticle-based imaging agents for X-ray/computed tomography |
WO2007088051A2 (en) | 2006-01-31 | 2007-08-09 | Bayer Schering Pharma Aktiengesellschaft | Modulation of mdl-1 activity for treatment of inflammatory disease |
CA2967254C (en) | 2008-02-29 | 2019-03-26 | Lantheus Medical Imaging, Inc. | Contrast agents for applications including imaging cancer |
CN102088907B (zh) * | 2008-07-07 | 2013-03-27 | 皇家飞利浦电子股份有限公司 | K边缘成像 |
CN102458396B (zh) | 2009-04-15 | 2017-05-10 | 兰休斯医疗成像公司 | 使用抗坏血酸稳定化放射性药物组合物 |
WO2011035140A1 (en) | 2009-09-18 | 2011-03-24 | Paka Pulmonary Pharmaceuticals, Inc. | Methods and compositions for delivery of contrast moieties to the lungs |
CN109200296B (zh) | 2010-02-08 | 2021-12-14 | 兰休斯医疗成像公司 | 用于合成显像剂和其中间体的方法和装置 |
EP2540321A1 (en) | 2011-06-30 | 2013-01-02 | Bayer Intellectual Property GmbH | Bis Tridentate W3O2 Clusters for X-Ray imaging |
AU2013203000B9 (en) | 2012-08-10 | 2017-02-02 | Lantheus Medical Imaging, Inc. | Compositions, methods, and systems for the synthesis and use of imaging agents |
EP2733148A1 (en) | 2012-11-15 | 2014-05-21 | Bayer Pharma Aktiengesellschaft | Tungsten complexes with di-dentate ligands |
WO2014144708A1 (en) | 2013-03-15 | 2014-09-18 | The Regents Of The University Of California | Peptides having reduced toxicity that stimulate cholesterol efflux |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US468759A (en) | 1892-02-09 | Gabeiel a | ||
US3860611A (en) * | 1972-01-19 | 1975-01-14 | Du Pont | Macrocyclic polyether polyols and condensation polymers derived therefrom |
US3763188A (en) * | 1972-01-19 | 1973-10-02 | Du Pont | Spiro(1,1-polyethylenedi(oxymethyl))-3-oxetanes |
US3952015A (en) * | 1973-11-12 | 1976-04-20 | Carl George Krespan | Macrocyclic compounds having oxa and aza linkages in the ring and containing spirooxetane groups |
US4079124A (en) * | 1976-04-21 | 1978-03-14 | Medi-Physics, Inc. | Method of preparing X-ray contrast media containing ores of hafnium, tantalum and tungsten |
US4176173A (en) * | 1977-07-18 | 1979-11-27 | Medi-Physics, Inc. | Radiographic compositions |
US4647447A (en) * | 1981-07-24 | 1987-03-03 | Schering Aktiengesellschaft | Diagnostic media |
US4652519A (en) | 1983-02-03 | 1987-03-24 | Yeda Research And Development Company Limited | Bifunctional chelating agents and process for their production |
US4826673A (en) | 1985-01-09 | 1989-05-02 | Mallinckrodt, Inc. | Methods and compositions for enhancing magnetic resonance imaging |
CA1282069C (en) | 1985-09-12 | 1991-03-26 | Damon L. Meyer | Antibody complexes of hapten-modified diagnostic or therapeutic agents |
US4795698A (en) * | 1985-10-04 | 1989-01-03 | Immunicon Corporation | Magnetic-polymer particles |
IT1213029B (it) | 1986-01-30 | 1989-12-07 | Bracco Ind Chimica Spa | Chelati di ioni metallici paramagnetici. |
DE3869251D1 (de) | 1987-07-16 | 1992-04-23 | Nycomed As | Aminopolycarbonsaeure und ihre derivate. |
FR2630547A1 (fr) * | 1988-04-22 | 1989-10-27 | Centre Nat Rech Scient | Marquage froid de molecules de nature peptidique ou proteique |
AU628403B2 (en) * | 1988-09-29 | 1992-09-17 | Access Pharmaceuticals, Inc. | Methods and compositions for magnetic resonance imaging |
US5260050A (en) * | 1988-09-29 | 1993-11-09 | Ranney David F | Methods and compositions for magnetic resonance imaging comprising superparamagnetic ferromagnetically coupled chromium complexes |
GB9006977D0 (en) * | 1990-03-28 | 1990-05-23 | Nycomed As | Compositions |
US5186923A (en) * | 1990-10-10 | 1993-02-16 | Brigham And Womens Hospital | Enhancement of cellular accumulation of lipophilic cationic organometallic compounds by reduction of intramembrane potential |
WO1993002713A1 (en) * | 1991-08-05 | 1993-02-18 | Mallinckrodt Medical, Inc. | Heavy metal clusters for use as imaging agents |
-
1990
- 1990-03-28 GB GB909006977A patent/GB9006977D0/en active Pending
-
1991
- 1991-03-27 ES ES91906843T patent/ES2091323T3/es not_active Expired - Lifetime
- 1991-03-27 SG SG1996005936A patent/SG43931A1/en unknown
- 1991-03-27 DE DE69122092T patent/DE69122092T2/de not_active Expired - Fee Related
- 1991-03-27 JP JP3506810A patent/JPH06507147A/ja active Pending
- 1991-03-27 CA CA002079212A patent/CA2079212A1/en not_active Abandoned
- 1991-03-27 WO PCT/EP1991/000587 patent/WO1991014460A1/en active IP Right Grant
- 1991-03-27 HU HU923086V patent/HU9203086D0/hu unknown
- 1991-03-27 DK DK91906843.7T patent/DK0521977T3/da active
- 1991-03-27 EP EP91906843A patent/EP0521977B1/en not_active Expired - Lifetime
- 1991-03-27 EP EP94203047A patent/EP0645146A1/en not_active Withdrawn
- 1991-03-27 AT AT91906843T patent/ATE142508T1/de not_active IP Right Cessation
- 1991-03-27 AU AU75578/91A patent/AU645796B2/en not_active Ceased
- 1991-03-27 HU HU9203086A patent/HUT69168A/hu unknown
- 1991-03-27 US US07/927,484 patent/US5458869A/en not_active Expired - Fee Related
-
1992
- 1992-09-25 FI FI924297A patent/FI924297A0/fi unknown
- 1992-09-25 NO NO92923739A patent/NO923739L/no unknown
- 1992-12-30 LV LVP-92-681A patent/LV10056B/lv unknown
-
1993
- 1993-06-03 LT LTIP609A patent/LT3535B/lt not_active IP Right Cessation
-
1994
- 1994-12-22 US US08/363,163 patent/US5614168A/en not_active Expired - Fee Related
-
1996
- 1996-12-24 HK HK219596A patent/HK219596A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GB9006977D0 (en) | 1990-05-23 |
DE69122092T2 (de) | 1997-03-06 |
EP0645146A1 (en) | 1995-03-29 |
LTIP609A (en) | 1994-12-27 |
ATE142508T1 (de) | 1996-09-15 |
NO923739D0 (no) | 1992-09-25 |
CA2079212A1 (en) | 1991-09-29 |
JPH06507147A (ja) | 1994-08-11 |
US5458869A (en) | 1995-10-17 |
HU9203086D0 (en) | 1992-12-28 |
AU7557891A (en) | 1991-10-21 |
FI924297A (fi) | 1992-09-25 |
WO1991014460A1 (en) | 1991-10-03 |
ES2091323T3 (es) | 1996-11-01 |
US5614168A (en) | 1997-03-25 |
LT3535B (en) | 1995-11-27 |
LV10056A (lv) | 1994-05-10 |
HK219596A (en) | 1997-01-03 |
EP0521977A1 (en) | 1993-01-13 |
HUT69168A (en) | 1995-08-28 |
LV10056B (en) | 1995-02-20 |
NO923739L (no) | 1992-11-06 |
FI924297A0 (fi) | 1992-09-25 |
SG43931A1 (en) | 1997-11-14 |
AU645796B2 (en) | 1994-01-27 |
DE69122092D1 (de) | 1996-10-17 |
EP0521977B1 (en) | 1996-09-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69122092D1 (de) | Kontrastmittel | |
NO931631D0 (no) | Kompleksdannende midler og maalsoeking av radioaktive immunoreagenser nyttige innen terapeutiske og diagnostiske bildedannende sammensetninger og fremgangsmetoder | |
FI93830B (fi) | Typpipitoisia syklisiä ligandeja, menetelmä niiden valmistamiseksi sekä niiden käyttö metallikompleksien ja näitä komplekseja sisältävien diagnostisten koostumusten valmistamiseksi | |
ATE185490T1 (de) | Röntgenkontrastmittel | |
ES2120961T3 (es) | Composicion anti-trombogena y/o anti-microbiana. | |
ATE187340T1 (de) | Kontrastmittel | |
DK163289D0 (da) | Ligander, og kationiske komplekser deraf med technetium-99m | |
ES2073505T3 (es) | Medios de contraste. | |
DK0384122T3 (da) | Mutanter af humant antithrombin III | |
DK266689D0 (da) | Kationiske komplekser med technetium-99m | |
DK638088D0 (da) | Substituerede dicarboxylsyre-bis(3,5-dicarbamoyl-2,4,6-trijodanilider), fremgangsmaade til fremstilling deraf samt roentgenkontrastmidler indeholdende disse | |
NO971318D0 (no) | Jodiserte röntgenkontrastmidler | |
DE3673227D1 (de) | 99mtc(iii)-agenzien zur myokardialen darstellung, in vivo nichtreduzierbar. | |
NO913403D0 (no) | Ikke-ioniske joderte forbindelser, fremgangsmaate for deres fremstilling og kontrastmidler inneholdende de samme forbindelser. | |
DE69128584D1 (de) | In Cyclodextrinen eingeschlossene Steroide | |
ATE134988T1 (de) | Neue vorangeordnete sechszähnige liganden verwendbar in röntgenologischen bildformenden wirkstoffen | |
KR900016139A (ko) | 도파민 수용체 리간드와 영상화제 | |
RU93051087A (ru) | Иодированные ароилоксикарбоксамиды, рентгеноконтрастная композиция и способ получения рентгеновского изображения | |
RU92016532A (ru) | Бензохиназолиновые соединения, способ их получения, фармацевтическая композиция и способ лечения | |
IT1242026B (it) | Composizione farmaceutica contenente un complesso ferro-schizokinene per il trattamento dell'anemia ferropenica. | |
IT1265251B1 (it) | Derivati iodurati del bifenile e loro impiego diagnostico |